In summary, our data demonstrate that EC‐ACKR1 and EC‐KDR‐IGFBP3 possess key characteristics of IMECs, and are involved in antigen presentation processes that specifically drive tumor‐specific immune responses, primarily for the recruitment of functional CD4+ T cells within the tumor. Here, IGFBP3 is linked to neoplasm.